Get informed when a big investor buys or sells
+ Follow444.16
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, 6634.TWO shows a PEG ratio of 444.16. That is above the Healthcare sector average of -6.46. Scroll down for historical charts and peer comparison views.
The Healthcare sector average PEG ratio is about -6.46. Sinew Pharma is at 444.16, which is higher that average. That is roughly 6973.5% above the sector mean. Use the comparison chart on this page to see how 6634.TWO stacks up against individual peers as well.
Investors watch 6634.TWO's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Sinew Pharma's latest reading is 444.16. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has Sinew Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 444.16) with ownership activity and broader fundamentals.
The Healthcare average PEG ratio is about -6.46, while 6634.TWO is at 444.16. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.